Share

Search your stocks

Ctrl+K

ACCPLAccretion Pharmaceuticals Ltd.

58.7(+0.00%)

1W: -0.51%

1M: -0.17%

1Y: -

Accretion Pharmaceuticals Quarterly Results

Pros & Cons

POSITIVES

Strong revenue growth in the latest quarter indicates robust demand for products, outperforming previous quarters.
Improved operating margins suggest better cost management and efficiency improvements compared to earlier periods.
Positive cash flow from operations highlights strengthened financial health, supporting future investments.

NEGATIVES

Declining net profit margins raise concerns about profitability sustainability, contrasting with prior quarters' performance.
Increased operating expenses due to inflationary pressures may hinder future growth potential.
Sales growth rate has slowed compared to previous quarters, indicating potential market saturation or increased competition.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-